What are the strengths and limitations of The New England Journal of Medicine Report when compared to other reports?
The major strength of The New England Journal of Medicine study is the collection of information from a large number of patients who were managed according to common medical practice. The major limitation of The New England Journal of Medicine study is that patients were not randomly assigned to any of the treatments (or to no treatment) for preventing bleeding. The treating physicians determined, based on their experience and judgment, whether to administer Trasylol, another drug to prevent bleeding, or no treatment. It is possible that the treating physicians may have chosen to administer Trasylol only to the sicker patients while the less sick patients received other products or no therapy to prevent bleeding. Consequently, the study outcomes may not truly indicate Trasylol side-effects. Instead, the study outcomes may indicate the seriousness of the underlying condition of the patients chosen to receive Trasylol. It is important to note that the study investigators used statistical
Related Questions
- What are the strengths and limitations of The New England Journal of Medicine Report when compared to other reports?
- Was Trasylol responsible for the serious side-effects detected in The New England Journal of Medicine report?
- How to customize the report generation such that to generate the needed reports only?
